Venture startup

Who invested in Magnolia NeuroSciences

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$18Mraised across 1 round since 2020, from 1 source

Latest round
Venture, $18MJul 2020
Investors
4
See who backed them

The rounds

  1. Jul 2020
    Venture$18M

    Source recordedSEC filing: $5.0M sold, first sale Jul 2020

Founders and team

From the SEC filings it signed: 3 on the team.

  • Ian HowesExecutive Officeri
  • Kendall MohlerExecutive Officeri
  • Thong LeExecutive Officer, Directori

On the board, as filediAlice LyMichael BaranSteve Gillis

Everyone who backed them

Lilly Asia VenturesVC firm1round
AbbVieCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Magnolia NeuroSciences

Who invested in Magnolia NeuroSciences?

Magnolia NeuroSciences's investors include ARCH Venture Partners, Alexandria Venture Investments, Lilly Asia Ventures and AbbVie.

How much has Magnolia NeuroSciences raised?

Magnolia NeuroSciences has raised $18M across 1 round since 2020.

When did Magnolia NeuroSciences last raise?

Magnolia NeuroSciences's most recent round was a Venture of $18M in Jul 2020.

What was Magnolia NeuroSciences's biggest round?

Its most recent round, $18M in Jul 2020, is also its largest on record.

Who backed Magnolia NeuroSciences first?

Magnolia NeuroSciences's first round on record, in Jul 2020, was backed by ARCH Venture Partners, Alexandria Venture Investments and Lilly Asia Ventures and 1 others.

What stage is Magnolia NeuroSciences at?

Magnolia NeuroSciences's latest named round is a Venture, in Jul 2020.

Companies like Magnolia NeuroSciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.